Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Rapid growth, or mild swelling?

It has been another rocky week for North American markets as traders continue to weigh the risks of inflation and the health of the financial sector. Canada’s own main stock index recently hit a two-week low, but in the face of every performance in the red...
Jonathon Brown | April 27, 2023 |

Gold is Rallying and This Junior Exploration Company is Riding a 40% Share Price Increase YTD

Gold has proven itself once again to be a safe-haven asset over the course of 2021. Although the yellow metal has corrected itself from its high of US$1,943.20 per ounce from earlier this year, the gold price is still sitting comfortably above the $1,800 mark. In tandem...
Jocelyn Aspa | October 5, 2021 |

Buzz on the Bullboards: Are We Headed for a Major Market Correction?

(Image via Datametrex AI Limited.) Datametrex AI Ltd. ( TSX-V: DM , Forum ) announced this week that achieved the highest net income and revenue in its history. A technology-focused company with exposure to Artificial Intelligence and Machine Learning, Datametr...
Stockhouse Editorial | August 18, 2021 |

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...
Marc Davis | August 3, 2021 |

Highly Prospective Multi-Million Oz. Gold Deposits. Where? Find Out Here.

(CLICK IMAGE TO PLAY VIDEO) Looking for a multi-million ounce gold opportunity in elephant country? Enter Angold Resources Ltd. ( TSX-V.AAU , OTCMKTS: AAUGF , Forum ) boasting four highly prospective properties in its balanced portfolio…including two in Chi...
Dave Jackson | July 22, 2021 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |

Cabin Fever and the Price of Gold

I've had a few comments lately on the pieces I have been writing about where we stand politically and with the Corona Virus. One complained and said that he loves my comments on markets but I was getting too political. Of course I am. I thought we had two totally diff...
Streetwise Reports | May 1, 2020 |

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...
Streetwise Reports | November 7, 2019 |